Clinical and brain imaging characteristics in leucine‐rich repeat kinase 2–associated PD and asymptomatic mutation carriers
Kathrin Brockmann(Oregon Health & Science University), Thomas Gasser(Hertie Institute for Clinical Brain Research), Adriana Di Santo(Hertie Institute for Clinical Brain Research), Inga Liepelt(Hertie Institute for Clinical Brain Research), Adriane Gröger(Hertie Institute for Clinical Brain Research), Walter Maetzler(Centre Hospitalier Universitaire de Lille), Uwe Klose(University of Tübingen), Claudia Schulte(School of the Art Institute of Chicago), Ann‐Kathrin Hauser(German Center for Neurodegenerative Diseases), Daniela Berg(Christian-Albrechts-Universität zu Kiel), Ruediger Hilker(Goethe University Frankfurt), Baltazar Gomez‐Mancilla(Novartis (Switzerland))
Cited by 79
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k